Mechanisms and therapeutic insights into MASH-associated fibrosis
Trends in Endocrinology & Metabolism · 2026-05 · 37 (5) · 402-417
DOI: 10.1016/j.tem.2025.09.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-05. Verfasst von Yiwei Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Vatche and Tamar Manoukian Division of Digestive Diseases, Univer…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Fatty Liver. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Vatche and Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA, USA; Division of Live…
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- NIGMS NIH HHS
- National Heart Lung and Blood Institute
- National Institute of General Medical Sciences
- National Institutes of Health
- Irma T Hirschl Trust
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Zhu, Y., & Cai, B. (2026). Mechanisms and therapeutic insights into MASH-associated fibrosis. Trends in Endocrinology & Metabolism, 37(5), 402-417. https://doi.org/10.1016/j.tem.2025.09.004
Vancouver
Zhu Y, Cai B. Mechanisms and therapeutic insights into MASH-associated fibrosis. Trends in Endocrinology & Metabolism. 2026;37(5):402-417. doi:10.1016/j.tem.2025.09.004
BibTeX
@article{Zhu2026,
author = {Zhu, Yiwei and Cai, Bishuang},
title = {Mechanisms and therapeutic insights into MASH-associated fibrosis},
journal = {Trends in Endocrinology & Metabolism},
year = {2026},
volume = {37},
number = {5},
pages = {402--417},
doi = {10.1016/j.tem.2025.09.004}
}
EUVIMED